Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo - PubMed (original) (raw)
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo
Koichi Inagaki et al. Circulation. 2003.
Abstract
Background: Current treatment for acute myocardial infarction (AMI) focuses on reestablishing blood flow (reperfusion). Paradoxically, reperfusion itself may cause additional injury to the heart. We previously found that delta-protein kinase C (deltaPKC) inhibition during simulated ischemia/reperfusion in isolated rat hearts is cardioprotective. We focus here on the role for deltaPKC during reperfusion only, using an in vivo porcine model of AMI.
Methods and results: An intracoronary application of a selective deltaPKC inhibitor to the heart at the time of reperfusion reduced infarct size, improved cardiac function, inhibited troponin T release, and reduced apoptosis. Using 31P NMR in isolated perfused mouse hearts, we found a faster recovery of ATP levels in hearts treated with the deltaPKC inhibitor during reperfusion only.
Conclusions: Reperfusion injury after cardiac ischemia is mediated, at least in part, by deltaPKC activation. This study suggests that including a deltaPKC inhibitor at reperfusion may improve the outcome for patients with AMI.
Similar articles
- Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts.
Tanaka M, Terry RD, Mokhtari GK, Inagaki K, Koyanagi T, Kofidis T, Mochly-Rosen D, Robbins RC. Tanaka M, et al. Circulation. 2004 Sep 14;110(11 Suppl 1):II194-9. doi: 10.1161/01.CIR.0000138389.22905.62. Circulation. 2004. PMID: 15364862 - Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
Inagaki K, Begley R, Ikeno F, Mochly-Rosen D. Inagaki K, et al. Circulation. 2005 Jan 4;111(1):44-50. doi: 10.1161/01.CIR.0000151614.22282.F1. Epub 2004 Dec 20. Circulation. 2005. PMID: 15611364 - Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
Inagaki K, Hahn HS, Dorn GW 2nd, Mochly-Rosen D. Inagaki K, et al. Circulation. 2003 Aug 19;108(7):869-75. doi: 10.1161/01.CIR.0000081943.93653.73. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860903 - Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P, Schulz R, Baxter GF. Ferdinandy P, et al. Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29. Pharmacol Rev. 2007. PMID: 18048761 Review. - Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury.
Budas GR, Churchill EN, Mochly-Rosen D. Budas GR, et al. Pharmacol Res. 2007 Jun;55(6):523-36. doi: 10.1016/j.phrs.2007.04.005. Epub 2007 Apr 29. Pharmacol Res. 2007. PMID: 17576073 Review.
Cited by
- PKCδ is an activator of neuronal mitochondrial metabolism that mediates the spacing effect on memory consolidation.
Comyn T, Preat T, Pavlowsky A, Plaçais PY. Comyn T, et al. Elife. 2024 Oct 30;13:RP92085. doi: 10.7554/eLife.92085. Elife. 2024. PMID: 39475218 Free PMC article. - Cardiac troponin I directly binds and inhibits mitochondrial ATP synthase with a noncanonical role in the post-ischemic heart.
Elezaby A, Lin AJ, Vijayan V, Pokhrel S, Kraemer BR, Bechara LRG, Larus I, Sun J, Baena V, Syed ZA, Murphy E, Glancy B, Ostberg NP, Queliconi BB, Campos JC, Ferreira JCB, Haileselassie B, Mochly-Rosen D. Elezaby A, et al. Nat Cardiovasc Res. 2024 Aug;3(8):987-1002. doi: 10.1038/s44161-024-00512-1. Epub 2024 Jul 18. Nat Cardiovasc Res. 2024. PMID: 39196031 - PKCδ is an activator of neuronal mitochondrial metabolism that mediates the spacing effect on memory consolidation.
Comyn T, Preat T, Pavlowsky A, Plaçais PY. Comyn T, et al. bioRxiv [Preprint]. 2024 Jun 18:2023.10.06.561186. doi: 10.1101/2023.10.06.561186. bioRxiv. 2024. PMID: 38948698 Free PMC article. Updated. Preprint. - The pig as an optimal animal model for cardiovascular research.
Jia H, Chang Y, Song J. Jia H, et al. Lab Anim (NY). 2024 Jun;53(6):136-147. doi: 10.1038/s41684-024-01377-4. Epub 2024 May 21. Lab Anim (NY). 2024. PMID: 38773343 Review. - Mitochondrial Kinase Signaling for Cardioprotection.
Boengler K, Eickelmann C, Kleinbongard P. Boengler K, et al. Int J Mol Sci. 2024 Apr 19;25(8):4491. doi: 10.3390/ijms25084491. Int J Mol Sci. 2024. PMID: 38674076 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources